| CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
| 139755-83-2 | 西地那非; 1-[4-乙氧基-3-[5-(6,7-二氢-1-甲基-7-氧代-3-丙基-1H-吡唑并[4,3d]嘧啶)]苯磺酰]-4-甲基哌嗪 | Sildenafil; 5-[2-Ethoxy-5-(4-methylpiperazin-1-yl-sulphonyl)phenyl]-1-methyl-3-n-propyl-1,6-dihydro-7H-pyrazol[4,3d]pyrimidin-7-one | ![]() | C22H30N6O4S | 详情 | 供应商 |
| 639089-54-6 | 陶扎色替; N-[4-[[4-(4-甲基-1-哌嗪基)-6-[(5-甲基-1H-吡唑-3-基)氨基]-2-嘧啶基]硫]苯基]环丙烷甲酰胺 | Tozasertib; N-[4-[[4-(4-Methyl-1-piperazinyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]thio]phenyl]cyclopropanecarboxamide; MK 0457; VX 680 | ![]() | C23H28N8OS | 详情 | 供应商 |
| 760937-92-6 | 特力利汀; 3-[[(2S,4S)-4-[4-(3-甲基-1-苯基-1H-吡唑-5-基)-1-哌嗪基]-2-吡咯烷基]甲酰基]噻唑烷 | Teneligliptin; 3-[[(2S,4S)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-pyrrolidinyl]carbonyl]thiazolidine | ![]() | C22H30N6OS | 详情 | 供应商 |
| 827318-97-8 | 达鲁舍替; N-[5-((2R)-2-甲氧基-2-苯基乙酰基)-1,4,5,6-四氢吡咯并[3,4-c]吡唑-3-基]-4-(4-甲基哌嗪-1-基)苯 | Danusertib; N-[5-((2R)-2-Methoxy-2-phenylethanoyl)-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-yl]-4-(4-methylpiperazin-1-yl)benzamide | ![]() | C26H30N6O3 | 详情 | 供应商 |
| 934353-76-1 | 6-(4-甲基-1-哌嗪基)-N-(5-甲基-1H-吡唑-3-基)-2-[(1E)-2-苯乙烯基]-4-嘧啶胺; 6-(4-甲基-1-哌嗪基)-N-(5-甲 | 6-(4-Methyl-1-piperazinyl)-N-(5-methyl-1H-pyrazol-3-yl)-2-[(1E)-2-phenylethenyl]-4-pyrimidinamine; 6-(4-Methyl-1-piperazinyl)-N-(5-methyl-1H-pyrazol-3-yl)-2-[(1E)-2-phenylethenyl]-4-pyrimidinamine; ENMD-2076 | ![]() | C21H25N7 | 详情 | 供应商 |
| 1035270-39-3 | AZD-4547; REL-N-[5-[2-(3,5-二甲氧基苯基)乙基]-1H-吡唑-3-基]-4-[(3R,5S)-3,5-二甲基-1-哌嗪基]苯甲酰胺 | AZD-4547; AZD-4547; rel-N-[5-[2-(3,5-Dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-[(3R,5S)-3,5-dimethyl-1-piperazinyl]benzamide; AZD4547/AZD-4547 | 无 | 详情 | 供应商 | |
| 401566-79-8 | 1 - (3 - 甲基-1 - 苯基-1H-吡唑-5 - 基)哌嗪 | 1-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)piperazine | 无 | C14H18N4 | 详情 | 供应商 |
| 1572583-29-9 | [(2S,4S)-4-[4-(3-甲基-1-苯基-1H-吡唑-5-基)-1-哌嗪基]-2-吡咯烷基]-3-噻唑烷基甲酮氢溴酸盐水合物 | [(2S,4S)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-pyrrolidinyl]-3-thiazolidinylmeth | 无 | 详情 | 供应商 |